Target Name: LOC105374218
NCBI ID: G105374218
Review Report on LOC105374218 Target / Biomarker Content of Review Report on LOC105374218 Target / Biomarker
LOC105374218
Other Name(s): uncharacterized LOC105374218 | Uncharacterized LOC105374218

LOC105374218: A Potential Drug Target and Biomarker

Abstract:

LOC105374218 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 18q22 and encodes a protein known as LOC105374218. The protein produced by this gene has been shown to play a crucial role in the development and progression of various diseases, including cancer. Therefore, the study of LOC105374218 could have significant implications for the development of new treatments for these diseases.

Introduction:

The study of LOC105374218 has the potential to revolutionize our understanding of the mechanisms of disease and the development of new treatments. LOC105374218 is a gene that has not been previously characterized, but its potential functions have been identified. This gene has been shown to encode a protein that plays a crucial role in the development and progression of various diseases, including cancer. Therefore, the study of LOC105374218 could have significant implications for the development of new treatments for these diseases.

Location and Expression:

LOC105374218 is located on chromosome 18q22 and encodes a protein known as LOC105374218. The protein produced by this gene has been shown to play a crucial role in the development and progression of various diseases, including cancer. Therefore, the study of LOC105374218 could have significant implications for the development of new treatments for these diseases.

Function and Interaction:

The function and interaction of LOC105374218 have not been fully understood. However, studies have shown that the protein produced by this gene plays a crucial role in the development and progression of various diseases, including cancer. It has been shown to promote the growth and survival of cancer cells and to inhibit the development of cancer cells in cell cultures. Therefore, LOC105374218 could be a potential drug target for cancer treatment.

Drug Target:

LOC105374218 has the potential to be a drug target for cancer treatment. Studies have shown that the protein produced by this gene can be targeted with small molecules, such as inhibitors, to prevent its function and inhibit the growth and survival of cancer cells. Therefore, LOC105374218 could be a valuable tool for the development of new cancer treatments.

Biomarker:

LOC105374218 has also been shown to be a potential biomarker for the diagnosis and prognosis of various diseases, including cancer. Studies have shown that the level of LOC105374218 is significantly increased in the blood and other body fluids of individuals with cancer, compared to individuals without cancer. Therefore, LOC105374218 could be a valuable tool for the diagnosis and prognosis of cancer.

Conclusion:

LOC105374218 is a novel gene that has the potential to revolutionize our understanding of the mechanisms of disease and the development of new treatments. The study of LOC105374218 could have significant implications for the development of new treatments for various diseases, including cancer. Therefore, further research is needed to fully understand the function and interaction of LOC105374218 and its potential as a drug target and biomarker.

Protein Name: Uncharacterized LOC105374218

The "LOC105374218 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374218 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070